-
Product Insights
NewAntithrombin III – Drugs In Development, 2024
The Antithrombin III pipeline drugs market research report outlays comprehensive information on the Antithrombin III targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Hematological Disorders, Cardiovascular, and Infectious Disease which include indications of Antithrombin III Deficiency, Disseminated Intravascular Coagulation (DIC), Deep Vein Thrombosis (DVT), Venous Thromboembolism, and Sepsis. It also reviews key players involved in Antithrombin III...
-
Product Insights
NewCoagulation Factor X – Drugs In Development, 2024
The Coagulation Factor X pipeline drugs market research report outlays comprehensive information on the Coagulation Factor X targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Hematological Disorders, Central Nervous System, and Infectious Disease which include indications of Deep Vein Thrombosis (DVT), Venous Thromboembolism, Bleeding And Clotting Disorders, Hemophilia A (Factor VIII Deficiency), Brain Hemorrhage, and Sepsis....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Eltanexor in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Eltanexor in Metastatic Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Eltanexor in Metastatic Colorectal Cancer Drug Details: Eltanexor is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Edoxaban Tosylate in Chronic Thromboembolic Pulmonary Hypertension Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BAY-3018250 in Deep Vein Thrombosis (DVT)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - BAY-3018250 in Deep Vein Thrombosis (DVT) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. BAY-3018250 in Deep Vein Thrombosis (DVT) Drug Details: BAY-3018250...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FXIa Inhibitor in Deep Vein Thrombosis (DVT)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - FXIa Inhibitor in Deep Vein Thrombosis (DVT) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. FXIa Inhibitor in Deep Vein Thrombosis (DVT) Drug...
-
Product Insights
Likelihood of Approval Analysis for Bleeding And Clotting Disorders
Overview How likely is it that the drugs in Bleeding And Clotting Disorders will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bleeding And Clotting Disorders Overview Bleeding and clotting disorders are...
-
Product Insights
Likelihood of Approval Analysis for Deep Vein Thrombosis (DVT)
Overview How likely is it that the drugs in Deep Vein Thrombosis (DVT) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Deep Vein Thrombosis (DVT) Overview Deep vein thrombosis (DVT) is...
-
Product Insights
Likelihood of Approval Analysis for Thrombosis
Overview How likely is it that the drugs in Thrombosis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thrombosis Overview Thrombosis is the formation of a blood clot, known as a...
-
Product Insights
Likelihood of Approval Analysis for Venous Thromboembolism
Overview How likely is it that the drugs in Venous Thromboembolism will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Venous Thromboembolism Overview Venous thromboembolism (VTE) is a condition that occurs when...